Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use

Table 4 Economic and treatment-effort analysis of four sarcoptic mange treatment protocols for an adult bare-nosed wombat (Vombatus ursinus)

Product	Active ingredient	Dose	Volume (ml)	Administration frequency	Treatment duration (weeks)	Cost per application (AUD)^e	Cost per animal (AUD)^e	Treatment effort
Bravecto A^a	Fluralaner	25 mg/kg	3.57	Once	12	27.55	27.79	1
+ OP^b	N/A	N/A	≥ 6	Once	12	0.24	27.79	1
Bravecto B^a	Fluralaner	25 mg/kg	3.57	Monthly	12	27.55	83.37	3
+ OP^b	N/A	N/A	≥ 6	Monthly	12	0.24	83.37	3
Cydectin A^c	Moxidectin	0.2 mL/kg	5	Weekly	12	1.09	13.19	12
Cydectin B^d	Moxidectin	0.8 mL/kg	20	Weekly	15	4.40	65.99	15

Units of effort are relative to the total number of treatment applications required
^aBravecto Spot-on for Large Dogs
^bOrange Power Sticky Spot & Goo Dissolver
^cAs per Martin et al. [8]
^dAs per regime recently approved by Australian Pesticides and Veterinary Management Authority
^eAt time of writing

ISSN: 1756-3305